logo

Disease Markers

Disease Markers / Table of Contents

Table of Contents

Table of Contents

  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9826727
  • - Retraction

Retracted: Therapy Strategy of CD47 in Diffuse Large B-Cell Lymphoma (DLBCL)

Disease Markers
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9813461
  • - Retraction

Retracted: Study on the Killing Effect of γδT Cells Activated by Rukangyin on Breast Cancer MDA-MB-231 Cells

Disease Markers
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9807872
  • - Retraction

Retracted: Early Diagnosis and Treatment of Nine Patients with Severe Multiple Injuries Accompanied by Traumatic Aortic Dissection during Emergency Treatment

Disease Markers
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9801930
  • - Retraction

Retracted: KIF20A Predicts Poor Survival of Patients and Promotes Colorectal Cancer Tumor Progression through the JAK/STAT3 Signaling Pathway

Disease Markers
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9791279
  • - Retraction

Retracted: The Mechanism of Xiaoyao San in the Treatment of Ovarian Cancer by Network Pharmacology and the Effect of Stigmasterol on the PI3K/Akt Pathway

Disease Markers
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9790832
  • - Retraction

Retracted: A Meta-Analysis of Robotic Surgery in Endometrial Cancer: Comparison with Laparoscopy and Laparotomy

Disease Markers
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9784325
  • - Retraction

Retracted: Functional Characterization of a Missense Variant of MLH1 Identified in Lynch Syndrome Pedigree

Disease Markers
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9767143
  • - Retraction

Retracted: Study on the Effect of MRI in the Diagnosis of Benign and Malignant Thoracic Tumors

Disease Markers
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9761794
  • - Retraction

Retracted: Relationship between Long Noncoding RNA H19 Polymorphisms and Risk of Coronary Artery Disease in a Chinese Population: A Case-Control Study

Disease Markers
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9761720
  • - Retraction

Retracted: 6,12-Diphenyl-3, 9-diazatetraasterane-1, 5, 7, 11-tetracarboxylate Inhibits Proliferation, Migration and Promotes Apoptosis in Ovarian Cancer Cells

Disease Markers
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9761328
  • - Retraction

Retracted: Association between lncRNA GAS5, MEG3, and PCAT-1 Polymorphisms and Cancer Risk: A Meta-Analysis

Disease Markers
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9759372
  • - Retraction

Retracted: Environmental and Genetic Factors in the Pathogenesis of COPD in the Road-Working Population

Disease Markers
  • Disease Markers -
  • Special Issue
  • Volume 2023
  • - Article ID 1702125
  • - Research Article

Aldolase A Promotes Colorectal Cancer Progression through Targeting COPS6 and Regulating MAPK Signaling Pathway

Ya Lu | Yuan Zhang | ... | Jifeng Feng
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9861260
  • - Retraction

Retracted: Multiomics Immune-Related lncRNA Analysis of Oral Squamous Cell Carcinoma and Its Correlation with Prognosis

Disease Markers
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9860161
  • - Retraction

Retracted: Sappanone A Alleviated IL-1β-Induced Inflammation in OA Chondrocytes through Modulating the NF-κB and Nrf2/HO-1 Pathways

Disease Markers
Disease Markers
Journal metrics
See full report
Acceptance rate6%
Submission to final decision131 days
Acceptance to publication42 days
CiteScore3.700
Journal Citation Indicator-
Impact Factor-
See full report
APC$2550
Submit Check your manuscript for errors before submitting
Author guidelines Editorial board Databases and indexing

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.